Morning Overview on MSN
A common inflammation molecule may hijack dopamine pathways tied to addiction
Methamphetamine addiction has long been framed as a story of dopamine gone haywire, with the drug flooding the brain’s reward ...
CAMBRIDGE, Mass., Sept. 30, 2025 /PRNewswire/ -- Clear Scientific Inc., a clinical stage biopharmaceutical company focused on the development of first-in-class small molecules to reverse acute ...
A phase 2 trial evaluating CS-1103 in participants with methamphetamine use disorder is expected to begin in the first quarter of 2026. The Food and Drug Administration (FDA) has granted Fast Track ...
PsyPost on MSN
Neuroscientists link a common inflammatory molecule to the dopaminergic mechanisms of addiction
A new study published in the journal Science Signaling has found that an immune system protein plays a central role in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results